Which combination should be preferred in the management of children with chronic hepatitis B infection?

J Clin Gastroenterol. 2005 Sep;39(8):745-6. doi: 10.1097/01.mcg.0000173934.46654.1e.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Letter

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Child
  • Decision Making
  • Drug Therapy, Combination
  • Follow-Up Studies
  • Hepatitis B, Chronic / drug therapy*
  • Humans
  • Interferon-alpha / therapeutic use*
  • Lamivudine / therapeutic use*
  • Reverse Transcriptase Inhibitors / therapeutic use*
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Interferon-alpha
  • Reverse Transcriptase Inhibitors
  • Lamivudine